# AEOLUS PHARMACEUTICALS, INC.

AEOLUS PHARMACEUTICALS, INC. is a company headquartered in Mission Viejo, CA, United States.

## Company overview

- **Legal name:** AEOLUS PHARMACEUTICALS, INC.
- **Former names in filing history:** INCARA PHARMACEUTICALS CORP (2003-12-09 to 2004-07-20); INCARA INC (2003-09-19 to 2003-12-04)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Mission Viejo, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** September 30
- **SEC CIK:** 0001261734

## About

AEOLUS PHARMACEUTICALS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001261734, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-12-20, it reported net income of USD -3,558,000; total assets of USD 4,167,000 for the fiscal period ended 2016-09-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-09-30)

- **Net income:** -$3.6M (USD -3,558,000)
- **Total assets:** $4.2M (USD 4,167,000)
- **Cash and equivalents:** $3.2M (USD 3,155,000)
- **Operating cash flow:** -$3.1M (USD -3,109,000)

### FY2015 (period ended 2015-09-30)

- **Revenue:** $3.1M (USD 3,111,000)
- **Net income:** -$2.6M (USD -2,628,000)
- **Total assets:** $1.8M (USD 1,777,000)
- **Cash and equivalents:** $94,000 (USD 94,000)
- **Operating cash flow:** -$2.4M (USD -2,443,000)

### FY2014 (period ended 2014-09-30)

- **Revenue:** $9.6M (USD 9,631,000)
- **Net income:** -$80,000 (USD -80,000)
- **Total assets:** $3.6M (USD 3,580,000)
- **Cash and equivalents:** $1.5M (USD 1,517,000)
- **Operating cash flow:** $323,000 (USD 323,000)

### FY2013 (period ended 2013-09-30)

- **Revenue:** $3.9M (USD 3,928,000)
- **Net income:** -$3.2M (USD -3,208,000)
- **Total assets:** $2.0M (USD 1,966,000)
- **Cash and equivalents:** $869,000 (USD 869,000)
- **Operating cash flow:** -$3.0M (USD -2,970,000)

## Recent SEC filings

- Form 10-Q — filed 2017-08-14 — period 2017-06-30 — QUARTERLY REPORT
- Form 10-Q — filed 2017-05-15 — period 2017-03-31 — QUARTERLY REPORT
- Form 8-K — filed 2017-03-24 — period 2017-03-24 — CURRENT REPORT
- Form 10-Q — filed 2017-02-17 — period 2016-12-31 — QUARTERLY REPORT
- Form 10-K/A — filed 2017-01-30 — period 2016-09-30 — AMENDMENT TO ANNUAL REPORT
- Form S-1 — filed 2016-12-20 — AEOLUS PHARMACEUTICALS, INC. S-1
- Form 10-K — filed 2016-12-20 — period 2016-09-30 — AEOLUS PHARMACEUTICALS 10-K
- Form 8-K — filed 2016-09-13 — period 2016-09-08 — AEOLUS PHARMACEUTICALS, INC. 8-K
- Form 10-Q — filed 2016-08-15 — period 2016-06-30 — AEOLUS PHARMACEUTICALS, INC. 10-Q
- Form 8-K — filed 2016-05-26 — period 2016-05-25 — AEOLUS PHARMACEUTICALS 8-K
- Form 10-Q — filed 2016-05-16 — period 2016-03-31 — AEOLUS PHARMACEUTICALS, INC. 10-Q
- Form 8-K — filed 2016-02-23 — period 2016-02-23 — AEOLUS PHARMACEUTICALS, INC. 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/aeolus-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology